Navigation Links
46 gene sequencing test for cancer patients on the NHS
Date:3/25/2013

towards verifying the use of a test involving 150 genes.

Having a diagnostic test or 'panel' that can screen for mutations in multiple genes at once will be important for access to all the new cancer drugs that are coming along.

'It will be very difficult to manage in NHS diagnostic labs without gene panels,' explains Dr Schuh. 'Currently, new cancer drugs tend to get approved alongside a diagnostic test specific to that drug which can determine which patients will benefit. But as more and more drugs like this come along, we can't possibly run all the many different separate tests this could mean. We need one test for a range of drugs.'

Dr Taylor adds: 'We wanted a test that would use the latest DNA sequencing techniques to detect a wide range of mutations in a wide range of genes. A test that would be able to cover more cancers and more treatments, all for a similar cost to conventional methods.'

The test is run on a next generation sequencing platform from Life Technologies Corporation, called the Ion Personal Genome Machine (PGM(TM)). The test and accompanying software have been substantially modified as requested by the Oxford team to fulfil diagnostic standards in their lab.

This work was co-funded by the Technology Strategy Board, the UK's innovation agency, through a grant to the NIHR Oxford BRC, Life Technologies Corporation, AstraZeneca, and Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies.

As part of the test development, the Oxford team looked to improve the initial sample preparation in the lab, and to provide the software and infrastructure support to handle and analyse the amount of information involved. Most importantly, the Oxford group has carried out tests and comparisons to verify the robustness of the technique with cancer biopsies direct from patients.

The team compared the new 46 gene test against conventional techniques for 80 consecutive cancer bi
'/>"/>

Contact: Press Office
press.office@admin.ox.ac.uk
44-018-652-80530
University of Oxford
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Eurofins MWG Operon launches SmartSeq -- An innovative DNA sequencing solution for premixed samples
2. Human bacteria sequencing project involving CU raises $340,000 online
3. Gene sequencing project mines data once considered junk for clues about cancer
4. Genomic sequencing identifies mutant drivers of common brain tumor
5. High-throughput sequencing shows potentially hundreds of gene mutations related to autism
6. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
7. Surprising findings from NHLBI Exome Sequencing Project reported
8. NIH uses genome sequencing to help quell bacterial outbreak in Clinical Center
9. New Stanford method enables sequencing of fetal genomes using only maternal blood sample
10. Gene sequencing project identifies potential drug targets in common childhood brain tumor
11. Voices Against Brain Cancer Comments on Link Between Cell Phone Use and Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015 (PRWEB) April 01, 2015 The Path ... most extreme jungle adventure you could ever embark upon. Trips ... days. Endorsed by the Philippine Department of Tourism, these trips ... the rainforest, but very few people have ever been in ... Officer. , Armed with nothing more than a backpack full ...
(Date:4/1/2015)... 01, 2015 The Pennsylvania Court overseeing ... ( http://www.risperdallawsuit2014.com/ ) has scheduled a meeting for ... Philadelphia Court of Common Pleas, the meeting will commence ... Court records indicate that the proceeding will address the ... Risperdal users who experienced gynecomastia (male breast growth) and ...
(Date:4/1/2015)... SCI Solutions , the health industry’s ... that CEO Joel French will be a featured speaker ... in Chicago, April 12-16, 2015. French will co-present ... Coordination Strategies ” with Northeast Georgia Health System (NGHS) ... than 38,000 healthcare industry professionals are expected at the ...
(Date:4/1/2015)... 01, 2015 OSF Saint Paul Medical ... System , was welcomed into the Ministry April 1, ... Msgr. Paul E. Showalter, vicar general of the Catholic ... Dedication culminated a nearly year-long transition process for the ... hospital. Speakers for the morning ceremony included Sister Judith ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 IQ Formulations ... health and nutritional supplement companies in the U.S., today is ... testing and quality control standards for its herbal supplements.* GNC ... supply chain to ensure the accuracy of labeling on its ... veteran and IQ Formulations CEO Jay Cohen said: ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2
... Dec. 11, 2007 Researchers at UT Southwestern Medical ... of Cushing syndrome, a metabolic disorder caused by adrenal ... The study, appearing in the December issue of the ... surgical outcomes reported in patients with subclinical Cushing syndrome ...
... Call Scheduled for December 18, 2007, MISSION VIEJO, ... ENSG ), the parent company of the Ensign(TM) group ... today that it expects to issue its fiscal third,quarter ... December,18, 2007., Conference Call, A live webcast ...
... tomorrow, Tuesday, December 11, 2007 at 8:45 ... ... Inc.,(Nasdaq: MEDX ) and Bristol-Myers Squibb Company (NYSE: BMY ) ... the monotherapy program for ipilimumab -- an investigational,immunotherapy -- in patients with ...
... The following statement,was released by Judie Brown of the American ... news reports that brought me face to,face with the tragic ... drugs, the English language and the preborn child. The reports ... The first of these reports centered on a drug that ...
... The Board of,Directors of the nonprofit Life and ... far to find the best candidate to,become the organization,s ... CLU, ChFC, RFC, will serve as the organization,s,president and ... holds the position as chairman of the LIFE board, ...
... The American Medical,Association (AMA) Foundation today announced the ... Inc to its fundraising campaign. The gift was ... program which supports physician-led free clinics providing direct,care ... donation will allow us to continue addressing the,growing ...
Cached Medicine News:Health News:UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy 2Health News:UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy 3Health News:The Ensign Group, Inc. to Announce Third Quarter 2007 Financial Results 2Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 2Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 3Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 4Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 5Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 6Health News:Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma 7Health News:Miscarriage of Justice: A Statement by Judie Brown of the American Life League 2Health News:Miscarriage of Justice: A Statement by Judie Brown of the American Life League 3Health News:Miscarriage of Justice: A Statement by Judie Brown of the American Life League 4Health News:LIFE Foundation Names Feldman Its Next President and CEO 2
(Date:4/1/2015)... DALLAS , April 1, 2015 /PRNewswire/ ... Research Report on Global Azithromycin Industry and ... Drug Industry reports added to Pharmaceutical category ... analysis, the report introduces Azithromycin basic information, ... industry overview, policy analysis, and news analysis, ...
(Date:4/1/2015)... 1, 2015 Jintian Pharmaceutical Group Limited ("Jintian ... Mr. Jin Dongtao, chairman and executive director purchased 40,000,000 ... of the existing entire issued share capital of the ... with the total amount of approximately HK$113 million. Upon ... will increase from 45.17% to 47.17%. ...
(Date:4/1/2015)... , Mar. 30, 2015 Research and Markets ... the "An Introduction to the Medical Device Directives" ... provides a detailed introduction to the European medical device ... are covered, the involvement of Notified Bodies, how to ... It will also cover the documentation necessary to apply ...
Breaking Medicine Technology:Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2
... Inc. (NYSE: WPI ) today announced ... reached a settlement with Mallinckrodt Inc. on outstanding ... Mallinckrodt,s Exalgo® (Hydromorphone Hydrochloride Extended-Release ) tablets.  Mallinckrodt ... the United States District Court for the District ...
... Pa., Jan. 26, 2012   ProPhase Labs, Inc., the ... October, November and December winners of its "Share Your Cause ... provides financial aid on charitable work in US communities, has ... Buddies of Milwaukie, OR; and Hannah,s Home of Mentor, OH ...
Cached Medicine Technology:Watson Reaches Settlement with Mallinckrodt Over Exalgo(R) 2Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign 2Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign 3Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign 4
Soft, autoclavable, and without conformer....
Size: Large. 24.50 mm by 26.00 mm. Clear lucite. Supplied sterile....
... x 80 mm. Storz offers the ... by Harvey A. Lincoff, M.D. ... sponge which is non-toxic and non-antigenic. ... to minimize scleral intrusion. These implants ...
... mm. Half oval. The original Scleral Sponge II ... been modified by Dr. Joseph Olk with this ... cell sponge which is non-toxic and non-antigenic. Implants ... intrusion. These implants are packaged sterile and sold ...
Medicine Products: